» Articles » PMID: 31513886

Exosomal MALAT1 Derived from Hepatic Cells is Involved in the Activation of Hepatic Stellate Cells Via MiRNA-26b in Fibrosis Induced by Arsenite

Overview
Journal Toxicol Lett
Publisher Elsevier
Specialty Toxicology
Date 2019 Sep 13
PMID 31513886
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

In the liver microenvironment, interactions among diverse types of hepatic cells are involved in liver fibrosis. In fibrotic tissues, exosomes act as transporters in intercellular communication. Long non-coding RNAs (lncRNAs) are involved in the activation of hepatic stellate cells (HSCs), which are participants in liver fibrosis. However, the functions of exosomal lncRNAs in liver fibrosis induced by arsenite are undefined. The purposes of the present study were (a) to determine if lncRNAs secreted from human hepatic (L-02) cells exposed to arsenite are shuttled to hepatic stellate LX-2 cells and (b) to establish their effects on LX-2 cells. In mice, MALAT1 was overexpressed in the progression of liver fibrosis induced by arsenite as well as in L-02 cells exposed to arsenite. Co-cultures with arsenite-treated L-02 cells induced the activation of LX-2 cells and overexpression of MALAT1. Arsenite-treated L-02 cells transported MALAT1 into LX-2 cells. Downregulation of MALAT1, which reduced the MALAT1 levels in exosomes derived from arsenite-treated L-02 cells, inhibited the activation of LX-2 cells. Additionally, exosomal MALAT1 derived from arsenite-treated L-02 cells promoted the activation of LX-2 cells via microRNA-26b regulation of COL1A2. Furthermore, circulating exosomal MALAT1 was up-regulated in people exposed to arsenite. In sum, exosomes derived from arsenite-treated hepatic cells transferred MALAT1 to HSCs, which induced their activation. These findings support the concept that, during liver fibrosis induced by arsenite, exosomal lncRNAs are involved in cell-cell communication.

Citing Articles

The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis.

Sartorius K, Wang Y, Sartorius B, Antwi S, Li X, Chuturgoon A Funct Integr Genomics. 2025; 25(1):24.

PMID: 39847120 DOI: 10.1007/s10142-024-01519-4.


Dysregulation of Long Non-coding RNAs-the Novel lnc in Metal Toxicity and Carcinogenesis.

Wang Z, Wang P, Yang C Curr Environ Health Rep. 2024; 12(1):3.

PMID: 39715843 PMC: 11755759. DOI: 10.1007/s40572-024-00468-1.


Exosome-mediated Transfer of lncRNA in Liver Associated Diseases; Uncovered Truths.

Saleh R, Hamad H, Najim M, Menon S, Kaur M, Sivaprasad G Cell Biochem Biophys. 2024; .

PMID: 39567423 DOI: 10.1007/s12013-024-01617-x.


Schistosoma japonicum infection-mediated downregulation of lncRNA Malat1 contributes to schistosomiasis hepatic fibrosis by the Malat1/miR-96/Smad7 pathway.

Jiang P, Ye S, Fan X, Tian Y, Zhang D, Pan W Parasit Vectors. 2024; 17(1):413.

PMID: 39363237 PMC: 11451255. DOI: 10.1186/s13071-024-06499-9.


Dynamic role of exosomal long non-coding RNA in liver diseases: pathogenesis and diagnostic aspects.

Ismail M, Fadul M, Taha R, Siddig O, Elhafiz M, Yousef B Hepatol Int. 2024; 18(6):1715-1730.

PMID: 39306594 DOI: 10.1007/s12072-024-10722-1.